●founderA high-profile AI brand attempting a hardware medical pivot with no disclosed regulatory or clinical strategy — useful as a cautionary example of scope expansion risk.
●healthNo clinical evidence or FDA submission details are disclosed, making it impossible to assess diagnostic validity or regulatory viability at this stage.